Latest 8-K filings

Stereotaxis announced robust second-quarter 2026 results, with robotic catheter revenue surging 270% sequentially, alongside strategic acquisitions and positive future outlook for profitability.

AnaptysBio, Inc. announced the outcomes of its 2026 Annual Meeting of Stockholders, including the election of directors, ratification of its auditor, and approval of an amendment to its equity incentive plan.

Immunome announced its second quarter 2026 financial results, highlighting the FDA's acceptance of the New Drug Application for varegacestat with a PDUFA target action date of April 28, 2027, and providing updates on its clinical pipeline.

The Boston Beer Company has initiated a 10b5-1 plan to repurchase up to $25 million of its Class A Common Stock.

Chaince Digital Holdings Inc. announced a registered direct offering expected to raise approximately $16.2 million to fund its digital asset, tokenization, and capital markets strategies.

Optex Systems Holdings reported a decrease in Q3 fiscal 2026 revenue to $9.7 million from $11.1 million year-over-year, primarily due to delayed contract awards and delivery schedules, though gross margins improved significantly.

Bolt Biotherapeutics reported Q2 2026 financial results, highlighting ongoing BDC-4182 Phase 1/2 study progress with initial data expected in Q3 2026, while noting a significant decrease in collaboration revenue and an increase in net loss.

Kyverna Therapeutics announced second quarter 2026 financial results, highlighting FDA RMAT designation for miv-cel in naSPMS and progress on BLA submission for SPS.

Achieve Life Sciences announced a significant private placement and leadership enhancements, while also detailing a delay in its cytisinicline New Drug Application resubmission due to manufacturing observations.

enGene Therapeutics Inc. hosted a KOL event on August 11, 2026, to present market research on non-muscle-invasive bladder cancer (NMIBC) and discuss its investigational therapy, detalimogene.

AN2 Therapeutics reported Q2 2026 results, detailing progress in Phase 2 trials for polycythemia vera and Chagas disease, alongside pipeline expansion and increased R&D spending.

Federal Realty OP LP has issued $460 million in 3.500% Exchangeable Senior Notes due 2031, alongside capped call transactions to mitigate dilution.

Fold Holdings, Inc. announced its second quarter 2026 financial results, reporting $6.1 million in revenue and a net loss of $9.7 million, while highlighting progress in its credit card program and debt reduction.

Onfolio Holdings Inc. shareholders have overwhelmingly approved critical proposals at the 2026 Annual Meeting, including director elections, auditor ratification, and significant corporate actions related to stock issuance and authorized share increases.

Smart Sand, Inc. announced record second quarter 2026 results, including record sales volumes and revenues, alongside a planned leadership transition for its Chief Financial Officer.

Apogee Therapeutics stockholders overwhelmingly approved the merger agreement with AbbVie, paving the way for the acquisition.

Thryv Holdings has replaced its 2026 Short-Term Incentive Plan with a new 'Bridge Plan' for the second half of 2026, adjusting performance targets and opportunities to align with a recently announced company restructuring.

Velo3D announced robust second quarter 2026 financial results, featuring a 52.3% year-over-year revenue increase to $20.7 million and an improved gross margin of 21.5%, leading to an upward revision of full-year revenue guidance.

TherapeuticsMD reported a decrease in net income and license revenue for Q2 2026, alongside an increase in operating expenses, while continuing to explore strategic alternatives.

Worksport Ltd. announced record Q2 net sales of $5.23 million, a 27.4% year-over-year increase, alongside a 32% sequential reduction in net loss and a 58% decrease in operating cash use.

Berkshire Hathaway Inc. announced a substantial increase in net earnings for the second quarter and first six months of 2026, driven by strong operating results and significant investment gains.

Spruce Power Holding Corporation has adjourned its 2026 annual meeting of stockholders to August 25, 2026, following the approval of an adjournment proposal.

Free Flow USA, Inc. announces the resignation of its independent registered public accounting firm, BCRG Group, Inc., and the appointment of GSKCA & Associates as its successor.

National HealthCare Corporation declared a quarterly common dividend of $0.67 per share, payable on October 30, 2026.

National HealthCare Corporation announced robust second quarter 2026 results, with net operating revenues increasing 8.8% to $408,025,000, primarily due to the acquisition of five skilled nursing facilities.

PLAYSTUDIOS reported a 7.3% year-over-year revenue decrease to $55.0 million and a widened net loss of $13.3 million for Q2 2026, impacted by legacy portfolio pressures and underperforming new games.

Ares Real Estate Income Trust Inc. announced an increase in its monthly gross distributions per share, effective August 2026.

AMETEK, Inc. has significantly increased its commercial paper program, enhancing its capacity for funding operations and strategic acquisitions.

Auburn National Bancorporation, Inc. announced the declaration of its third quarter cash dividend of $0.27 per share.

Bluerock Homes Trust, Inc. has completed the disposition of 26 single-family residential units within the Golden Pacific portfolio for approximately $7.2 million, while also reporting pro forma net losses for the periods ended March 31, 2026, and December 31, 2025.